Upsher-Smith Laboratories
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Upsher-Smith Laboratories sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Upsher-Smith Laboratories: 5 sponsored US clinical trials, 1 recruiting.
Upsher-Smith Laboratories sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypogonadism, Male, with 1 trials.
Upper-quartile sponsor footprint
Upsher-Smith Laboratories sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
NCT04748601
Vogelxo(R) ABPM Study in Hypogandal Men
NCT04558567
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
NCT02856802
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
NCT01191086
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
NCT01142193
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
Where Upsher-Smith Laboratories enrollment is open (later-stage tilt)
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Hypogonadism, Male (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Upsher-Smith Laboratories: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Upsher-Smith Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Upsher-Smith Laboratories page
5 registered trials is a research-attention snapshot, not an endorsement of Upsher-Smith Laboratories or any single study.
- 1 of Upsher-Smith Laboratories's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypogonadism, Male is the condition Upsher-Smith Laboratories studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypogonadism, Male trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Upsher-Smith Laboratories pipeline card: 5 registered trials from official public datasets.Report a data error.